139 related articles for article (PubMed ID: 23000864)
21. Efficacy of cotrimoxazole and rifampin for 6 or 8 weeks of therapy in childhood brucellosis.
Roushan MR; Mohraz M; Janmohammadi N; Hajiahmadi M
Pediatr Infect Dis J; 2006 Jun; 25(6):544-5. PubMed ID: 16732154
[TBL] [Abstract][Full Text] [Related]
22. Efficacy of prolonged antimicrobial chemotherapy for brucellar spondylodiscitis.
Ioannou S; Karadima D; Pneumaticos S; Athanasiou H; Pontikis J; Zormpala A; Sipsas NV
Clin Microbiol Infect; 2011 May; 17(5):756-62. PubMed ID: 20518794
[TBL] [Abstract][Full Text] [Related]
23. Treatment of brucella spondylitis: lessons from an impossible meta-analysis and initial report of efficacy of a fluoroquinolone-containing regimen.
Pappas G; Seitaridis S; Akritidis N; Tsianos E
Int J Antimicrob Agents; 2004 Nov; 24(5):502-7. PubMed ID: 15519485
[TBL] [Abstract][Full Text] [Related]
24. Treatment of human brucellosis.
Solera J
J Med Liban; 2000; 48(4):255-63. PubMed ID: 11214198
[TBL] [Abstract][Full Text] [Related]
25. Doxycycline plus streptomycin versus ciprofloxacin plus rifampicin in spinal brucellosis [ISRCTN31053647].
Alp E; Koc RK; Durak AC; Yildiz O; Aygen B; Sumerkan B; Doganay M
BMC Infect Dis; 2006 Apr; 6():72. PubMed ID: 16606473
[TBL] [Abstract][Full Text] [Related]
26. A multicenter therapeutic study of 1100 children with brucellosis.
Lubani MM; Dudin KI; Sharda DC; Ndhar DS; Araj GF; Hafez HA; al-Saleh QA; Helin I; Salhi MM
Pediatr Infect Dis J; 1989 Feb; 8(2):75-8. PubMed ID: 2649867
[TBL] [Abstract][Full Text] [Related]
27. Clinical findings, diagnostic approach, and outcome of Brucella melitensis epididymo-orchitis.
Colmenero JD; Muñoz-Roca NL; Bermudez P; Plata A; Villalobos A; Reguera JM
Diagn Microbiol Infect Dis; 2007 Apr; 57(4):367-72. PubMed ID: 17141451
[TBL] [Abstract][Full Text] [Related]
28. A randomized, double-blind study to assess the optimal duration of doxycycline treatment for human brucellosis.
Solera J; Geijo P; Largo J; Rodriguez-Zapata M; Gijón J; Martinez-Alfaro E; Navarro E; Macia MA;
Clin Infect Dis; 2004 Dec; 39(12):1776-82. PubMed ID: 15578399
[TBL] [Abstract][Full Text] [Related]
29. Comparison of the efficacy of two months of treatment with co-trimoxazole plus doxycycline vs. co-trimoxazole plus rifampin in brucellosis.
Roushan MR; Gangi SM; Ahmadi SA
Swiss Med Wkly; 2004 Sep; 134(37-38):564-8. PubMed ID: 15551160
[TBL] [Abstract][Full Text] [Related]
30. [Antibiotic treatment of brucellosis].
Bertrand A
Presse Med; 1994 Jun; 23(24):1128-31. PubMed ID: 7971834
[TBL] [Abstract][Full Text] [Related]
31. Brucellar spondylitis: review of 25 cases.
Yilmaz E; Parlak M; Akalin H; Heper Y; Ozakin C; Mistik R; Oral B; Helvaci S; Töre O
J Clin Rheumatol; 2004 Dec; 10(6):300-7. PubMed ID: 17043537
[TBL] [Abstract][Full Text] [Related]
32. Brucellar spondylodiscitis: a case report.
Aydin G; Tosun A; Keles I; Ayaşlioglu E; Tosun O; Orkun S
Int J Clin Pract; 2006 Nov; 60(11):1502-5. PubMed ID: 16669838
[TBL] [Abstract][Full Text] [Related]
33. Brucellosis: a retrospective evaluation of 99 cases and review of brucellosis treatment.
Demirtürk N; Demirdal T; Erben N; Demir S; Asci Z; Kilit TP; Kartal ED
Trop Doct; 2008 Jan; 38(1):59-62. PubMed ID: 18302876
[TBL] [Abstract][Full Text] [Related]
34. Efficacy of several antibiotic combinations against Brucella melitensis Rev 1 experimental infection in BALB/c mice.
Grilló MJ; De Miguel MJ; Muñoz PM; Marín CM; Ariza J; Blasco JM
J Antimicrob Chemother; 2006 Sep; 58(3):622-6. PubMed ID: 16849379
[TBL] [Abstract][Full Text] [Related]
35. [Treatment of human brucellosis with rifampicin].
Godeau P; Fuchs G; Guillevin L; Philippon A; Tucat G; Cabane J; Herson S
Sem Hop; 1984 Jan; 60(1):5-9. PubMed ID: 6320435
[TBL] [Abstract][Full Text] [Related]
36. A case of brucellar spondylodiscitis involving the cervical spine.
Nas K; Bükte Y; Ustün C; Cevik R; Geyik MF; Batmaz I
J Back Musculoskelet Rehabil; 2009; 22(2):121-3. PubMed ID: 20023340
[TBL] [Abstract][Full Text] [Related]
37. Paravertebral abscess and neurological deficits in cervical brucellar spondylitis.
German V; Papadopoulos N; Diakalis C; Goritsas C; Ferti A
East Mediterr Health J; 2010 Apr; 16(4):448-50. PubMed ID: 20795433
[No Abstract] [Full Text] [Related]
38. Antibiotic susceptibility and treatment of brucellosis.
Al-Tawfiq JA; Memish ZA
Recent Pat Antiinfect Drug Discov; 2013 Apr; 8(1):51-4. PubMed ID: 22812615
[TBL] [Abstract][Full Text] [Related]
39. Therapeutic options for human brucellosis.
Al-Tawfiq JA
Expert Rev Anti Infect Ther; 2008 Feb; 6(1):109-20. PubMed ID: 18251668
[TBL] [Abstract][Full Text] [Related]
40. Update on brucellosis: therapeutic challenges.
Solera J
Int J Antimicrob Agents; 2010 Nov; 36 Suppl 1():S18-20. PubMed ID: 20692127
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
